Login / Signup
David M Fairlamb
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 4
Top Topics
Double Blind
Drug Induced
Spinal Cord
Phase Ii
Top Venues
International wound journal
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
David M Fairlamb
,
Kinga Szepeshazi
,
David J A Goldsmith
,
Peter Danos
,
Hadar A Lev-Tov
,
Nathan Young
,
Jason Hanft
,
Charles M Zelen
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
International wound journal
21 (3) (2024)
David M Fairlamb
,
Kinga Szepeshazi
,
David J A Goldsmith
,
Peter Danos
,
Hadar A Lev-Tov
,
Nathan Young
,
Jason Hanft
,
Charles M Zelen
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
International wound journal
21 (3) (2024)
David M Fairlamb
,
Kinga Szepeshazi
,
David J A Goldsmith
,
Peter Danos
,
Hadar A Lev-Tov
,
Nathan Young
,
Jason Hanft
,
Charles M Zelen
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
International wound journal
21 (3) (2024)
David M Fairlamb
,
Bela Kelety
,
Anke Bachert
,
Anika Scholtissek
,
Richard D Jones
,
Stephen C Davis
,
Robert S Kirsner
Preliminary evidence supporting a new enzymatic debridement product for use in chronic wounds.
International wound journal
(2023)